Clinicogenomic Predictors of Survival and Intracranial Progression after Stereotactic Radiosurgery for Colorectal Cancer Brain Metastases
C. Gui, L.R.G. Pike, Brandon S. Imber(Memorial Sloan Kettering Cancer Center), Kenny Yu(Memorial Sloan Kettering Cancer Center), Ahmet Turan Ilıca(University Radiology), Yao Yu, Rona Yaeger(Memorial Sloan Kettering Cancer Center), J.A. Strong(University of Cincinnati Medical Center), Paolo Manca(Fondazione IRCCS Istituto Nazionale dei Tumori), Michael B. Foote(Memorial Sloan Kettering Cancer Center), Steven B. Maron(Memorial Sloan Kettering Cancer Center), Lillian A. Boe(Memorial Sloan Kettering Cancer Center), Yoshihito Yamada, Kirin Mueller, James A. Wilcox(La Trobe University), Henry Walch(Memorial Sloan Kettering Cancer Center), Nicolai A. Schultz, J. Eichholz
International Journal of Radiation Oncology*Biology*Physics
September 27, 2024
Cited by 0
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction
|Proceedings of the National Academy of Sciences|1998|1.1k
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365